ArticlePloS one2023

Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.

Naoya Maekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.